Healing Touch and Relaxation Therapies in Cervical Cancer Patients

This study has been completed.
Information provided by:
National Center for Complementary and Integrative Health (NCCIH)
ClinicalTrials.gov Identifier:
First received: June 7, 2004
Last updated: July 9, 2009
Last verified: July 2009
The purpose of this study is to evaluate the effects of healing touch and relaxation therapy on cervical cancer patients undergoing chemotherapy and radiation treatment.

Condition Intervention Phase
Cervix Neoplasms
Behavioral: Healing Touch Therapy
Behavioral: Relaxation Therapy
Behavioral: Standard Care
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Healing Touch in Advanced Cervical Cancer Patients: Immune Effects and Mechanisms

Resource links provided by NLM:

Further study details as provided by National Center for Complementary and Integrative Health (NCCIH):

Primary Outcome Measures:
  • natural killer cell cytotoxicity [ Time Frame: Baseline to week 6 ] [ Designated as safety issue: No ]
  • T-cell counts [ Time Frame: Baseline to week 6 ] [ Designated as safety issue: No ]
  • side effects [ Time Frame: Baseline to week 6 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • distress [ Time Frame: Baseline to week 6 ] [ Designated as safety issue: No ]
  • WBC and RBC [ Time Frame: Baseline to week 6 ] [ Designated as safety issue: No ]
  • days of treatment delay [ Time Frame: Baseline to week 6 ] [ Designated as safety issue: No ]
  • salivary cortisol [ Time Frame: Baseline to post-treatment ] [ Designated as safety issue: No ]

Enrollment: 60
Study Start Date: September 2002
Study Completion Date: April 2007
Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Healing Touch
Healing Touch Therapy
Behavioral: Healing Touch Therapy
Active Comparator: Relaxation Therapy
Relaxation Therapy
Behavioral: Relaxation Therapy
Placebo Comparator: Standard Care
Standard Care
Behavioral: Standard Care
Standard Care

Detailed Description:

The side effects of chemotherapy and radiation treatment are often severe and can have devastating effects on the mental and physical well-being of cancer patients. This study will determine whether healing touch and relaxation therapy are effective in minimizing the side effects of chemotherapy and radiation treatment in cervical cancer patients.

Participants in this study will receive weekly chemotherapy and daily radiation treatments for 6 weeks. Participants will be randomly assigned to receive either standard care (SC), SC plus relaxation therapy, or SC plus healing touch therapy. The relaxation therapy consists of progressive muscle relaxation and guided imagery. The healing touch therapy involves an energy-based modality in which health care practitioners stimulate the energy fields surrounding the patient. A physician-completed assessment and measures of immune function will be used to assess the well-being and overall quality of life of participants.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Stage Ib1-IVa cervical cancer
  • Treatment with concurrent chemotherapy and radiation at the University of Iowa Hospitals and Clinics

Exclusion Criteria:

  • Immunosuppressive disorders
  • Use of immunosuppressive medications
  • Transplant recipient
  • Metastatic or recurrent cervical cancer
  • History of any other type of cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00084123

United States, Iowa
University of Iowa Hospital and Clinics
Iowa City, Iowa, United States, 52242
Sponsors and Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Principal Investigator: Susan K Lutgendorf, MD University of Iowa
  More Information

ClinicalTrials.gov Identifier: NCT00084123     History of Changes
Obsolete Identifiers: NCT00065091
Other Study ID Numbers: P20AT000756-01 
Study First Received: June 7, 2004
Last Updated: July 9, 2009
Health Authority: United States: Federal Government

Keywords provided by National Center for Complementary and Integrative Health (NCCIH):
Relaxation Techniques
Drug Therapy
Healing Touch

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Genital Diseases, Female
Genital Neoplasms, Female
Neoplasms by Site
Urogenital Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Uterine Neoplasms

ClinicalTrials.gov processed this record on May 26, 2016